Downgrades Buy Sell X

SILK Silk Road Medical

Argus

Upgrades Hold Buy X

SILK Silk Road Medical

Argus

$24

Upgrades Hold Buy X

SILK Silk Road Medical

Stifel

$9 $20

Initiated Buy X

SILK Silk Road Medical

Lake Street

$20

Upgrades Underperform Peer Perform X

SILK Silk Road Medical

Wolfe Research

Downgrades Buy Neutral X

SILK Silk Road Medical

B. Riley Securities

$54 $14

Downgrades Buy Sell X

SILK Silk Road Medical

Citigroup

$35 $8

Downgrades Buy Neutral X

SILK Silk Road Medical

CL King

Downgrades Buy Hold X

SILK Silk Road Medical

Stifel

$45 $12

Downgrades Buy Hold X

SILK Silk Road Medical

Argus

Initiated Outperform X

SILK Silk Road Medical

Oppenheimer

$30

Downgrades Buy Underperform X

SILK Silk Road Medical

BofA Securities

$51 $28

Downgrades Overweight Neutral X

SILK Silk Road Medical

JP Morgan

$50 $28

Initiated Buy X

SILK Silk Road Medical

CL King

$47

Downgrades Peer Perform Underperform X

SILK Silk Road Medical

Wolfe Research

$27

Upgrades Neutral Buy X

SILK Silk Road Medical

Citigroup

$50

Initiated Buy X

SILK Silk Road Medical

B. Riley Securities

$58

Upgrades Sell Neutral X

SILK Silk Road Medical

Citigroup

$50

Downgrades Outperform Peer Perform X

SILK Silk Road Medical

Wolfe Research

Initiated Buy X

SILK Silk Road Medical

BofA Securities

$60

Downgrades Neutral Sell X

SILK Silk Road Medical

Citigroup

$33

Upgrades Sell Neutral X

SILK Silk Road Medical

Citigroup

$50

Downgrades Neutral Sell X

SILK Silk Road Medical

Citigroup

$50

Initiated Outperform X

SILK Silk Road Medical

BMO Capital Markets

Initiated Neutral X

SILK Silk Road Medical

BofA/Merrill

$43

Initiated Overweight X

SILK Silk Road Medical

JP Morgan

$45

Initiated Buy X

SILK Silk Road Medical

Stifel

$44

SILK  Silk Road Medical, Inc.

Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.